I call this another case of "figures never lie, but liars often figure." Sure, they can show data indicating that a large percentage of middle-aged or older tissue valve patients never have a re-op, but when they calculate their survival stats, do they eliminate all deaths from non-valve-related causes? (e.g. Do they present a "relative survival rate?") If not, this is not a valid conclusion. If they do, then they may have a case. But then, how many of those seniors who have failing tissue valves have other conditions that preclude another surgery, or they are simply inclined to let things go their course? All of this could distort the statistical relationships the authors are trying to promote.
Also, for those patients having failing tissue valves and who are not candidates for another OHS, there does remain the potential for TAVI, even now. It may not be perfect, and it may not offer the "full" life span of a conventional tissue valve, but it could avoid death at that time and afford some additional lifetime to the patient.
Each successive "generation" of tissue valves is "expected" to last longer than the predecessor generations, but they are not old enough yet for us to have any large-scale statistics regarding their durability. As I've said before, I don't remember seeing anywhere that a tissue valve manufacturer showed the range of life span that their valves have experienced, only the median lifespan. And, they all speak of "freedom from explant" but not mortality. So. . . thinking for my own case, if I need a re-op for my tissue valve at age 75, and if I remain in good/strong health, I have decent odds of surviving another valve surgery. Not that I look forward to it, but I certainly wouldn't be the oldest patient to do so.